glp-1 and protein The Diet: What to Eat (and What to Avoid) for Sustainable Results The GLP-1 Support System –

[Google Scholar] 6.Knop FK, Brnden A, Vilsbll T

It is added because it addresses two specific and significant clinical problems that arise from GLP-1 receptor agonist therapy: nausea at treatment initiation and progressive B12 depletion over the course of long-term use

Cell 179, 11291143

By combining peripheral effects (slower gastric emptying, metabolic adjustments) with central nervous system actions (reduced hunger and altered food reward), GLP-1 RAs produce sustained reductions in caloric intake and clinically meaningful weight loss

Participants were randomly assigned in a 1:1 ratio to receive either semaglutide 50 mg or a placebo once daily for 68 weeks